Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Designation crawled date : 2021 - 09 - 09 save search
Freeline Announces Orphan Drug Designations for FLT201 for the Treatment of Gaucher DiseaseClinical trial site initiation for Gaucher disease Type 1 on track by year end
Published: 2021-09-09 (Crawled : 15:00) - biospace.com/
FRLN | $6.48 0.0% 0
|
Health Technology
|
| O: 0.0%
H: 1.61%
C: -0.25%
disease treatment orphan drug drug trial pons designation
VOR33 Granted U.S. FDA Fast Track Designation for AML
Published: 2021-09-09 (Crawled : 14:00) - biospace.com/
VOR | $1.68 10K
|
|
| O: 3.85%
H: 3.03%
C: -3.21%
fda fda fast track fast track granted fast track designation grant designation aml
FDA grants Jardiance® Breakthrough Therapy designation for heart failure with preserved ejection fraction
Published: 2021-09-09 (Crawled : 14:00) - biospace.com/
LLY | $745.04 -0.12% 410K
|
Health Technology
|
| O: -0.61%
H: 0.29%
C: -5.25%
fda heart therapy breakthrough therapy granted grant designation
FDA Grants Breakthrough Device Designation to the NovoTTF-200T™ System for Advanced Liver Cancer
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
NVCR | $12.05 -0.08% 540
|
Health Technology
|
| O: 1.9%
H: 3.69%
C: 0.07%
fda cancer device liver granted grant designation
Decibel Therapeutics Receives Orphan Drug and Rare Pediatric Disease Designations for DB-OTO for the Treatment of Otoferlin-Related Congenital Hearing Loss
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
DBTX | $4.91 -0.81% -0.2% 0
|
Health Technology
|
| O: 4.66%
H: 3.72%
C: -2.85%
disease treatment rare pediatric disease designation orphan drug drug hearing loss designation rare
Eloxx Pharmaceuticals Announces Fast Track Designation for ELX-02 for the Treatment of Cystic Fibrosis Patients with Nonsense Mutations
Published: 2021-09-09 (Crawled : 12:00) - globenewswire.com
ELOX | $0.94 -2.34% 93K
|
Health Technology
|
| O: 5.76%
H: 14.29%
C: 4.08%
treatment fibrosis fast track fast track designation elx-02 designation cystic fibrosis
FDA Grants Soligenix Orphan Drug Designation for the Treatment of T-cell Lymphoma
Published: 2021-09-09 (Crawled : 12:00) - biospace.com/
SNGX | $0.4353 -14.65% -21.43% 73K
|
Health Technology
|
| O: 12.38%
H: 4.24%
C: -1.69%
treatment fda drug t-cell granted grant designation
Gainers vs Losers
| 69% | 31% |
Top 10 Gainers
AGBA | News | $1.4 250.0% 35M
|
Finance
ZCMD | $2.18 50.35% 24M
|
Commercial Services
RWOD | $12.0 50.06% 3.9M
|
n/a
AULT | $0.3174 31.1% 28M
|
Manufacturing
WISA 4 | $7.11 20.71% 4.7M
|
Electronic Technology
INDO | $4.9 20.1% 2.2M
|
Energy Minerals
LIFW | News | $0.99 19.26% 800K
|
Administrative and Support and ...
PRTG | $0.285 18.75% 140K
|
Mining, Quarrying, and Oil and ...
NURO | $4.32 18.36% 66K
|
Health Technology
HUBC | $1.52 17.83% 4.7M
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.